For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Whitehawk Therapeutics Inc (NASDAQ: WHWK) closed at $2.42 in the last session, down -2.02% from day before closing price of $2.47. In other words, the price has decreased by -$2.02 from its previous closing price. On the day, 0.16 million shares were traded. WHWK stock price reached its highest trading level at $2.49 during the session, while it also had its lowest trading level at $2.39.
Ratios:
We take a closer look at WHWK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.76 and its Current Ratio is at 16.76. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
. In the most recent recommendation for the company, Piper Sandler on August 27, 2024, Downgraded its rating to Neutral and sets its target price to $1.75 from $5 previously.
Jefferies Downgraded its Buy to Hold on August 21, 2024, whereas the target price for the stock was revised from $11 to $1.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when BALL BRYAN sold 2,147 shares for $2.35 per share. The transaction valued at 5,045 led to the insider holds 102,853 shares of the business.
Giacobello Scott M. sold 2,806 shares of WHWK for $6,594 on Mar 03 ’25. The CHIEF FINANCIAL OFFICER now owns 23,944 shares after completing the transaction at $2.35 per share. On Mar 03 ’25, another insider, Lennon David James, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 5,690 shares for $2.35 each. As a result, the insider received 13,372 and left with 33,429 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WHWK now has a Market Capitalization of 114050632 and an Enterprise Value of -48546364. As of this moment, Whitehawk’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.93 while its Price-to-Book (P/B) ratio in mrq is 0.73. Its current Enterprise Value per Revenue stands at -3.375 whereas that against EBITDA is 0.448.
Stock Price History:
The Beta on a monthly basis for WHWK is 0.47, which has changed by -0.2133758 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, WHWK has reached a high of $3.81, while it has fallen to a 52-week low of $1.39. The 50-Day Moving Average of the stock is 3.61%, while the 200-Day Moving Average is calculated to be 23.49%.
Shares Statistics:
According to the various share statistics, WHWK traded on average about 1.77M shares per day over the past 3-months and 164930 shares per day over the past 10 days. A total of 47.13M shares are outstanding, with a floating share count of 26.20M. Insiders hold about 44.40% of the company’s shares, while institutions hold 45.39% stake in the company. Shares short for WHWK as of 1765756800 were 760566 with a Short Ratio of 0.43, compared to 1763078400 on 978190. Therefore, it implies a Short% of Shares Outstanding of 760566 and a Short% of Float of 2.15.
Earnings Estimates
The stock of Whitehawk Therapeutics Inc (WHWK) is currently drawing attention from 1 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.27 and low estimates of -$0.27. Analysts are recommending an EPS of between -$0.25 and -$0.25 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$1.16, with 1.0 analysts recommending between -$1.16 and -$1.16.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for WHWK’s current fiscal year. The highest revenue estimate was $107.1M, while the lowest revenue estimate was $7M, resulting in an average revenue estimate of $40.41M. In the same quarter a year ago, actual revenue was $25.98M
